1. Molecular Pathology of Genitourinary Cancers: Translating the Cancer Genome to the Clinic
   Joshua I. Warrick et al, 2015, Genomic Applications in Pathology CrossRef
2. Potential Role for Targeted Therapy in Muscle-Invasive Bladder Cancer
   Anirban P. Mitra et al, 2015, Urologic Clinics of North America CrossRef
3. Identification of CNGB1 as a Predictor of Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
   Anastasia C. Hepburn et al, 2021, Cancers CrossRef
4. A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
   Huihuang Li et al, 2022, Frontiers in Genetics CrossRef
5. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model
   Peng-fei Liu et al, 2015, Oncotarget CrossRef
6. Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment
   Ali Hashemi Gheinani et al, 2024, Nature Reviews Urology CrossRef
7. Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
   Alexander S. Baras et al, 2015, PLOS ONE CrossRef
8. Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer
   K. Iwasaki et al, 2013, Japanese Journal of Clinical Oncology CrossRef
9. Actionable mutations in muscle-invasive bladder cancer
   Richard M. Bambury et al, 2013, Current Opinion in Urology CrossRef
10. A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer
    Yoichiro Kato et al, 2018, Oncology Letters CrossRef
11. Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer
    Consuelo Buttigliero et al, 2017, Cancer Treatment Reviews CrossRef
12. Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
    Giovanni Motterle et al, 2020, European Urology Focus CrossRef
13. Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder
    Ekaterina Laukhtina et al, 2022, Current Opinion in Urology CrossRef
14. Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study
    Ko Okabe et al, 2018, Japanese Journal of Clinical Oncology CrossRef
15. Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
    Neal Murphy et al, 2022, Oncotarget CrossRef
16. Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?
    Huyen T. Nguyen et al, 2017, Bladder Cancer CrossRef
17. Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review
    Ekaterina Laukhtina et al, 2021, Urologic Oncology: Seminars and Original Investigations CrossRef